These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12915336)

  • 1. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam.
    Klitgaard H; Pitkänen A
    Epileptic Disord; 2003 May; 5 Suppl 1():S9-16. PubMed ID: 12915336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drugs and neuroprotection: current status and future roles.
    Willmore LJ
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies.
    Łukawski K; Andres-Mach M; Czuczwar M; Łuszczki JJ; Kruszyński K; Czuczwar SJ
    Pharmacol Rep; 2018 Apr; 70(2):284-293. PubMed ID: 29477036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.
    Löscher W; Hönack D; Rundfeldt C
    J Pharmacol Exp Ther; 1998 Feb; 284(2):474-9. PubMed ID: 9454787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new frontier in epilepsy: novel antiepileptogenic drugs.
    Sasa M
    J Pharmacol Sci; 2006; 100(5):487-94. PubMed ID: 16799261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.
    Stepień K; Tomaszewski M; Czuczwar SJ
    Pharmacol Rep; 2005; 57(6):719-33. PubMed ID: 16382190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V; Pierguidi L; Tambasco N
    Brain Dev; 2011 Apr; 33(4):289-93. PubMed ID: 20630672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model.
    Stratton SC; Large CH; Cox B; Davies G; Hagan RM
    Epilepsy Res; 2003 Feb; 53(1-2):95-106. PubMed ID: 12576171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Epileptogenic Effects of Antiepileptic Drugs.
    Miziak B; Konarzewska A; Ułamek-Kozioł M; Dudra-Jastrzębska M; Pluta R; Czuczwar SJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats.
    Gu J; Lynch BA; Anderson D; Klitgaard H; Lu S; Elashoff M; Ebert U; Potschka H; Löscher W
    Eur J Neurosci; 2004 Jan; 19(2):334-45. PubMed ID: 14725628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
    Glien M; Brandt C; Potschka H; Löscher W
    Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy.
    Russo E; Citraro R; Scicchitano F; De Fazio S; Di Paola ED; Constanti A; De Sarro G
    Epilepsia; 2010 Aug; 51(8):1560-9. PubMed ID: 19919665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.
    Löscher W; Brandt C
    Pharmacol Rev; 2010 Dec; 62(4):668-700. PubMed ID: 21079040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model.
    Vinogradova LV; van Rijn CM
    Epilepsia; 2008 Jul; 49(7):1160-8. PubMed ID: 18397292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model.
    Ohno Y; Ishihara S; Terada R; Serikawa T; Sasa M
    Epilepsy Res; 2010 May; 89(2-3):360-4. PubMed ID: 20138737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.